Allied Healthcare Products
AHPI
AHPI was delisted on the 2nd of February, 2023.
9 hedge funds and large institutions have $886K invested in Allied Healthcare Products in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
3% more capital invested
Capital invested by funds: $861K → $886K (+$25K)
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$24.7K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$21.4K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$13.7K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$613 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$15.5K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5.6K |
AHPI Hedge Fund Activity: Q4 2017 in Review
9 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q4 2017, worth a combined $886K — up 2.9% from $861K a quarter earlier.
Fund positioning in AHPI was balanced in Q4 2017: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 2 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $24.7K. The largest seller was Wells Fargo, cutting an estimated $15.5K.
- 9 institutional investors held Allied Healthcare Products (AHPI) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $886K of Allied Healthcare Products stock for Q4 2017, up 2.9% quarter-over-quarter.
- 1 fund opened new Allied Healthcare Products positions in Q4 2017 and 1 closed out, a net change of 0 holders.
- The largest Allied Healthcare Products buyer in Q4 2017 was Renaissance Technologies, an estimated $24.7K added.
- The largest Allied Healthcare Products seller in Q4 2017 was Wells Fargo, an estimated $15.5K sold.
Based on aggregated 13F filings for Q4 2017.